[2025-10-01T21:12:09.569905] [QUERYOME] Starting research for query 836: 'Instructions:
 Answer the question below. First, respond with the single best option letter (A, B, C, or D). Then provide a concise reasoning (1–3 sentences). Use both the retrieved evidence and your own medical knowledge to choose the most accurate answer.

Question:
Which of the following change can be done in insulin structure so that there is least change in the function of insulin:

Options:
A. Interchange of A1 & A4
B. Interchange of B29 and B30
C. Interchange of A5 & A6
D. Breaking disulphide linkages'
[2025-10-01T21:12:09.611549] [PI] Starting research for query: 'Instructions:
 Answer the question below. First, respond with the single best option letter (A, B, C, or D). Then provide a concise reasoning (1–3 sentences). Use both the retrieved evidence and your own medical knowledge to choose the most accurate answer.

Question:
Which of the following change can be done in insulin structure so that there is least change in the function of insulin:

Options:
A. Interchange of A1 & A4
B. Interchange of B29 and B30
C. Interchange of A5 & A6
D. Breaking disulphide linkages'
[2025-10-01T21:12:09.612980] Saving text to bench_final/run1/medmcqa/medmcqa_2396/pi_initial_prompt.txt
[2025-10-01T21:12:09.617281] [PI] Calling o3 for initial analysis...
[2025-10-01T21:12:20.094529] [PI] Reasoning iteration 1
[2025-10-01T21:12:20.096468] [PI reasoning] **Exploring insulin modifications**

I’m thinking about changes in insulin's structure that affect its function and how to make modifications with the least impact. Insulin has two chains: A (21 amino acids) and B (30 amino acids), connected by disulfide bonds. There are crucial residues for receptor binding at the B chain's N-terminus. Interchanging amino acids might disrupt function, but changes like the lispro modification swap residues at B28 and B29, not B29 and B30. This swap is noteworthy!
[2025-10-01T21:12:20.098391] [PI] Executing function call 1: hybrid_search
[2025-10-01T21:12:20.104900] [PI] Function arguments: {'query': 'insulin B29 B30 interchange effect function', 'k': 10, 'faiss_weight': 0.6, 'bm25_weight': 0.4, 'use_rrf': True}
[2025-10-01T21:12:20.106937] Saving JSON to bench_final/run1/medmcqa/medmcqa_2396/pi_iteration_1_tool_call_2_hybrid_search.json
[2025-10-01T21:12:21.471613] [PI] Function hybrid_search executed successfully
[2025-10-01T21:12:21.473418] Saving JSON to bench_final/run1/medmcqa/medmcqa_2396/pi_iteration_1_tool_result_2_hybrid_search.json
[2025-10-01T21:12:21.479208] [PI] Continuing reasoning with 1 function responses...
[2025-10-01T21:12:34.769677] [PI] Reasoning iteration 2
[2025-10-01T21:12:34.771364] [PI reasoning] **Analyzing insulin modifications**

Publication #1 discusses the role of the C-terminus residues B26-B30 and their modifications—which still allow for receptor affinity. It looks like these modifications have minimal effects, especially when interchanging residues B29 and B30. However, if B29 (Lys) and B30 (Thr) are swapped, that could lead to a different sequence which might have a more significant impact. It seems earlier findings also show that deleting residues B26-B30 doesn't necessarily decrease potency, which is interesting.
[2025-10-01T21:12:34.773647] [PI] No function calls found in response
[2025-10-01T21:12:34.774956] [PI] No more function calls - research complete
[2025-10-01T21:12:34.776729] Saving text to bench_final/run1/medmcqa/medmcqa_2396/pi_final_answer.txt
[2025-10-01T21:12:34.780319] [QUERYOME] Query completed successfully
